NCT05538767View on ClinicalTrials.gov

Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm

PHASE2CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

September 16, 2022

Primary Completion Date

April 11, 2023

Study Completion Date

April 11, 2023

Conditions
Hookworm Infections
Interventions
DRUG

Emodepside

Treatment with Emodepside 30 mg

DRUG

Albendazole 400mg

Treatment with Albendazole 400 mg

Trial Locations (1)

122

Public Health Laboratory Ivo de Carneri, Chake Chake

All Listed Sponsors
collaborator

Public Health Laboratory Ivo de Carneri

OTHER

lead

Jennifer Keiser

OTHER